nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorthalidone—Hypomagnesaemia—Vandetanib—thyroid cancer	0.0394	0.0493	CcSEcCtD
Chlorthalidone—Hypercalcaemia—Vandetanib—thyroid cancer	0.036	0.0451	CcSEcCtD
Chlorthalidone—Tubulointerstitial nephritis—Vandetanib—thyroid cancer	0.0326	0.0409	CcSEcCtD
Chlorthalidone—Tubulointerstitial nephritis—Sorafenib—thyroid cancer	0.022	0.0276	CcSEcCtD
Chlorthalidone—Hyponatraemia—Vandetanib—thyroid cancer	0.0182	0.0228	CcSEcCtD
Chlorthalidone—Hypokalaemia—Vandetanib—thyroid cancer	0.0165	0.0207	CcSEcCtD
Chlorthalidone—Pancreatitis—Vandetanib—thyroid cancer	0.0154	0.0193	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Vandetanib—thyroid cancer	0.0143	0.0179	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Vandetanib—thyroid cancer	0.0141	0.0177	CcSEcCtD
Chlorthalidone—CA7—trachea—thyroid cancer	0.0132	0.114	CbGeAlD
Chlorthalidone—Hyponatraemia—Sorafenib—thyroid cancer	0.0123	0.0154	CcSEcCtD
Chlorthalidone—Arrhythmia—Vandetanib—thyroid cancer	0.0112	0.0141	CcSEcCtD
Chlorthalidone—Abdominal pain upper—Sorafenib—thyroid cancer	0.0112	0.014	CcSEcCtD
Chlorthalidone—Hypokalaemia—Sorafenib—thyroid cancer	0.0111	0.014	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.011	0.0138	CcSEcCtD
Chlorthalidone—Muscle spasms—Vandetanib—thyroid cancer	0.0105	0.0132	CcSEcCtD
Chlorthalidone—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EPO—thyroid cancer	0.0104	0.12	CbGpPWpGaD
Chlorthalidone—Pancreatitis—Sorafenib—thyroid cancer	0.0104	0.013	CcSEcCtD
Chlorthalidone—Abdominal discomfort—Sorafenib—thyroid cancer	0.0101	0.0127	CcSEcCtD
Chlorthalidone—Hypomagnesaemia—Epirubicin—thyroid cancer	0.00981	0.0123	CcSEcCtD
Chlorthalidone—Erectile dysfunction—Sorafenib—thyroid cancer	0.00974	0.0122	CcSEcCtD
Chlorthalidone—Jaundice—Sorafenib—thyroid cancer	0.00919	0.0115	CcSEcCtD
Chlorthalidone—Hypomagnesaemia—Doxorubicin—thyroid cancer	0.00908	0.0114	CcSEcCtD
Chlorthalidone—Hypercalcaemia—Epirubicin—thyroid cancer	0.00897	0.0112	CcSEcCtD
Chlorthalidone—CA4—neck—thyroid cancer	0.00883	0.0762	CbGeAlD
Chlorthalidone—Thrombocytopenia—Vandetanib—thyroid cancer	0.00873	0.0109	CcSEcCtD
Chlorthalidone—CA12—trachea—thyroid cancer	0.00858	0.074	CbGeAlD
Chlorthalidone—Hypercalcaemia—Doxorubicin—thyroid cancer	0.0083	0.0104	CcSEcCtD
Chlorthalidone—Paraesthesia—Vandetanib—thyroid cancer	0.00801	0.01	CcSEcCtD
Chlorthalidone—Decreased appetite—Vandetanib—thyroid cancer	0.00775	0.00972	CcSEcCtD
Chlorthalidone—Glycosuria—Epirubicin—thyroid cancer	0.00769	0.00964	CcSEcCtD
Chlorthalidone—Constipation—Vandetanib—thyroid cancer	0.00763	0.00956	CcSEcCtD
Chlorthalidone—Arrhythmia—Sorafenib—thyroid cancer	0.00756	0.00948	CcSEcCtD
Chlorthalidone—CA2—neck—thyroid cancer	0.00732	0.0632	CbGeAlD
Chlorthalidone—Glycosuria—Doxorubicin—thyroid cancer	0.00712	0.00892	CcSEcCtD
Chlorthalidone—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00709	0.00889	CcSEcCtD
Chlorthalidone—Muscle spasms—Sorafenib—thyroid cancer	0.00709	0.00889	CcSEcCtD
Chlorthalidone—Abdominal pain—Vandetanib—thyroid cancer	0.00705	0.00884	CcSEcCtD
Chlorthalidone—SLC12A1—head—thyroid cancer	0.00693	0.0598	CbGeAlD
Chlorthalidone—CA4—saliva-secreting gland—thyroid cancer	0.00689	0.0594	CbGeAlD
Chlorthalidone—Hyperuricaemia—Epirubicin—thyroid cancer	0.00672	0.00842	CcSEcCtD
Chlorthalidone—Leukopenia—Sorafenib—thyroid cancer	0.0066	0.00827	CcSEcCtD
Chlorthalidone—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00656	0.00823	CcSEcCtD
Chlorthalidone—Asthenia—Vandetanib—thyroid cancer	0.0064	0.00802	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Epirubicin—thyroid cancer	0.00635	0.00796	CcSEcCtD
Chlorthalidone—Hyperuricaemia—Doxorubicin—thyroid cancer	0.00622	0.00779	CcSEcCtD
Chlorthalidone—CA9—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—thyroid cancer	0.00621	0.0717	CbGpPWpGaD
Chlorthalidone—Diarrhoea—Vandetanib—thyroid cancer	0.0061	0.00765	CcSEcCtD
Chlorthalidone—CA5B—thyroid gland—thyroid cancer	0.00609	0.0525	CbGeAlD
Chlorthalidone—CA12—head—thyroid cancer	0.00602	0.052	CbGeAlD
Chlorthalidone—Dizziness—Vandetanib—thyroid cancer	0.0059	0.00739	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Sorafenib—thyroid cancer	0.00589	0.00739	CcSEcCtD
Chlorthalidone—Blood uric acid increased—Doxorubicin—thyroid cancer	0.00587	0.00736	CcSEcCtD
Chlorthalidone—Aplastic anaemia—Epirubicin—thyroid cancer	0.00585	0.00734	CcSEcCtD
Chlorthalidone—Anorexia—Sorafenib—thyroid cancer	0.00573	0.00719	CcSEcCtD
Chlorthalidone—CA2—saliva-secreting gland—thyroid cancer	0.00571	0.0493	CbGeAlD
Chlorthalidone—Vomiting—Vandetanib—thyroid cancer	0.00567	0.00711	CcSEcCtD
Chlorthalidone—Rash—Vandetanib—thyroid cancer	0.00562	0.00705	CcSEcCtD
Chlorthalidone—Dermatitis—Vandetanib—thyroid cancer	0.00562	0.00704	CcSEcCtD
Chlorthalidone—Headache—Vandetanib—thyroid cancer	0.00559	0.00701	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Epirubicin—thyroid cancer	0.00555	0.00696	CcSEcCtD
Chlorthalidone—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00541	0.00679	CcSEcCtD
Chlorthalidone—CA5B—head—thyroid cancer	0.0054	0.0466	CbGeAlD
Chlorthalidone—CA4—trachea—thyroid cancer	0.00531	0.0459	CbGeAlD
Chlorthalidone—Nausea—Vandetanib—thyroid cancer	0.0053	0.00664	CcSEcCtD
Chlorthalidone—Decreased appetite—Sorafenib—thyroid cancer	0.00523	0.00656	CcSEcCtD
Chlorthalidone—Diabetes mellitus—Epirubicin—thyroid cancer	0.0052	0.00652	CcSEcCtD
Chlorthalidone—Photosensitivity—Epirubicin—thyroid cancer	0.00515	0.00646	CcSEcCtD
Chlorthalidone—Constipation—Sorafenib—thyroid cancer	0.00514	0.00645	CcSEcCtD
Chlorthalidone—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00513	0.00644	CcSEcCtD
Chlorthalidone—Vascular purpura—Epirubicin—thyroid cancer	0.00506	0.00634	CcSEcCtD
Chlorthalidone—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00481	0.00603	CcSEcCtD
Chlorthalidone—Urticaria—Sorafenib—thyroid cancer	0.00478	0.00599	CcSEcCtD
Chlorthalidone—CA1—head—thyroid cancer	0.00477	0.0412	CbGeAlD
Chlorthalidone—Photosensitivity—Doxorubicin—thyroid cancer	0.00477	0.00598	CcSEcCtD
Chlorthalidone—Abdominal pain—Sorafenib—thyroid cancer	0.00476	0.00596	CcSEcCtD
Chlorthalidone—Purpura—Epirubicin—thyroid cancer	0.00469	0.00588	CcSEcCtD
Chlorthalidone—Vascular purpura—Doxorubicin—thyroid cancer	0.00468	0.00587	CcSEcCtD
Chlorthalidone—CA9—Cellular response to hypoxia—EPO—thyroid cancer	0.0046	0.0532	CbGpPWpGaD
Chlorthalidone—Hyponatraemia—Epirubicin—thyroid cancer	0.00454	0.00569	CcSEcCtD
Chlorthalidone—Hypersensitivity—Sorafenib—thyroid cancer	0.00443	0.00556	CcSEcCtD
Chlorthalidone—CA2—trachea—thyroid cancer	0.00441	0.038	CbGeAlD
Chlorthalidone—Purpura—Doxorubicin—thyroid cancer	0.00434	0.00545	CcSEcCtD
Chlorthalidone—Asthenia—Sorafenib—thyroid cancer	0.00432	0.00541	CcSEcCtD
Chlorthalidone—CA4—thyroid gland—thyroid cancer	0.0042	0.0363	CbGeAlD
Chlorthalidone—Hyponatraemia—Doxorubicin—thyroid cancer	0.0042	0.00527	CcSEcCtD
Chlorthalidone—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00413	0.00518	CcSEcCtD
Chlorthalidone—Abdominal pain upper—Epirubicin—thyroid cancer	0.00413	0.00518	CcSEcCtD
Chlorthalidone—Hypokalaemia—Epirubicin—thyroid cancer	0.00412	0.00516	CcSEcCtD
Chlorthalidone—Diarrhoea—Sorafenib—thyroid cancer	0.00412	0.00516	CcSEcCtD
Chlorthalidone—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00407	0.00511	CcSEcCtD
Chlorthalidone—Dizziness—Sorafenib—thyroid cancer	0.00398	0.00499	CcSEcCtD
Chlorthalidone—Eosinophilia—Epirubicin—thyroid cancer	0.00387	0.00485	CcSEcCtD
Chlorthalidone—Pancreatitis—Epirubicin—thyroid cancer	0.00383	0.00481	CcSEcCtD
Chlorthalidone—Vomiting—Sorafenib—thyroid cancer	0.00383	0.0048	CcSEcCtD
Chlorthalidone—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00382	0.00479	CcSEcCtD
Chlorthalidone—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00382	0.00479	CcSEcCtD
Chlorthalidone—Hypokalaemia—Doxorubicin—thyroid cancer	0.00381	0.00478	CcSEcCtD
Chlorthalidone—Rash—Sorafenib—thyroid cancer	0.00379	0.00476	CcSEcCtD
Chlorthalidone—Dermatitis—Sorafenib—thyroid cancer	0.00379	0.00475	CcSEcCtD
Chlorthalidone—CA5B—lymph node—thyroid cancer	0.00378	0.0326	CbGeAlD
Chlorthalidone—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00377	0.00473	CcSEcCtD
Chlorthalidone—Headache—Sorafenib—thyroid cancer	0.00377	0.00473	CcSEcCtD
Chlorthalidone—CA4—head—thyroid cancer	0.00373	0.0322	CbGeAlD
Chlorthalidone—Eosinophilia—Doxorubicin—thyroid cancer	0.00358	0.00449	CcSEcCtD
Chlorthalidone—Nausea—Sorafenib—thyroid cancer	0.00357	0.00448	CcSEcCtD
Chlorthalidone—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00357	0.00447	CcSEcCtD
Chlorthalidone—Pancreatitis—Doxorubicin—thyroid cancer	0.00355	0.00445	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Epirubicin—thyroid cancer	0.00353	0.00442	CcSEcCtD
Chlorthalidone—CA2—thyroid gland—thyroid cancer	0.00348	0.0301	CbGeAlD
Chlorthalidone—Jaundice—Epirubicin—thyroid cancer	0.0034	0.00426	CcSEcCtD
Chlorthalidone—CA1—lymph node—thyroid cancer	0.00334	0.0288	CbGeAlD
Chlorthalidone—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.0033	0.00414	CcSEcCtD
Chlorthalidone—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00326	0.00409	CcSEcCtD
Chlorthalidone—Agranulocytosis—Epirubicin—thyroid cancer	0.00325	0.00408	CcSEcCtD
Chlorthalidone—Jaundice—Doxorubicin—thyroid cancer	0.00314	0.00394	CcSEcCtD
Chlorthalidone—CA2—head—thyroid cancer	0.00309	0.0267	CbGeAlD
Chlorthalidone—Agranulocytosis—Doxorubicin—thyroid cancer	0.00301	0.00377	CcSEcCtD
Chlorthalidone—Arrhythmia—Epirubicin—thyroid cancer	0.0028	0.00351	CcSEcCtD
Chlorthalidone—CA9—Cellular response to hypoxia—HIF1A—thyroid cancer	0.00274	0.0317	CbGpPWpGaD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.0027	0.0312	CbGpPWpGaD
Chlorthalidone—Muscle spasms—Epirubicin—thyroid cancer	0.00262	0.00328	CcSEcCtD
Chlorthalidone—CA4—lymph node—thyroid cancer	0.00261	0.0225	CbGeAlD
Chlorthalidone—Arrhythmia—Doxorubicin—thyroid cancer	0.00259	0.00324	CcSEcCtD
Chlorthalidone—Agitation—Epirubicin—thyroid cancer	0.0025	0.00314	CcSEcCtD
Chlorthalidone—Vertigo—Epirubicin—thyroid cancer	0.00245	0.00307	CcSEcCtD
Chlorthalidone—Leukopenia—Epirubicin—thyroid cancer	0.00244	0.00306	CcSEcCtD
Chlorthalidone—Muscle spasms—Doxorubicin—thyroid cancer	0.00242	0.00304	CcSEcCtD
Chlorthalidone—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.00238	0.0275	CbGpPWpGaD
Chlorthalidone—Agitation—Doxorubicin—thyroid cancer	0.00232	0.0029	CcSEcCtD
Chlorthalidone—Vertigo—Doxorubicin—thyroid cancer	0.00226	0.00284	CcSEcCtD
Chlorthalidone—Leukopenia—Doxorubicin—thyroid cancer	0.00226	0.00283	CcSEcCtD
Chlorthalidone—Thrombocytopenia—Epirubicin—thyroid cancer	0.00218	0.00273	CcSEcCtD
Chlorthalidone—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.00217	0.025	CbGpPWpGaD
Chlorthalidone—CA2—lymph node—thyroid cancer	0.00216	0.0187	CbGeAlD
Chlorthalidone—Anorexia—Epirubicin—thyroid cancer	0.00212	0.00266	CcSEcCtD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.00212	0.0245	CbGpPWpGaD
Chlorthalidone—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00201	0.00253	CcSEcCtD
Chlorthalidone—Paraesthesia—Epirubicin—thyroid cancer	0.002	0.0025	CcSEcCtD
Chlorthalidone—Anorexia—Doxorubicin—thyroid cancer	0.00196	0.00246	CcSEcCtD
Chlorthalidone—Decreased appetite—Epirubicin—thyroid cancer	0.00193	0.00242	CcSEcCtD
Chlorthalidone—Constipation—Epirubicin—thyroid cancer	0.0019	0.00238	CcSEcCtD
Chlorthalidone—Paraesthesia—Doxorubicin—thyroid cancer	0.00185	0.00232	CcSEcCtD
Chlorthalidone—Decreased appetite—Doxorubicin—thyroid cancer	0.00179	0.00224	CcSEcCtD
Chlorthalidone—Urticaria—Epirubicin—thyroid cancer	0.00177	0.00221	CcSEcCtD
Chlorthalidone—Constipation—Doxorubicin—thyroid cancer	0.00176	0.00221	CcSEcCtD
Chlorthalidone—Abdominal pain—Epirubicin—thyroid cancer	0.00176	0.0022	CcSEcCtD
Chlorthalidone—Hypersensitivity—Epirubicin—thyroid cancer	0.00164	0.00205	CcSEcCtD
Chlorthalidone—Urticaria—Doxorubicin—thyroid cancer	0.00163	0.00205	CcSEcCtD
Chlorthalidone—Abdominal pain—Doxorubicin—thyroid cancer	0.00163	0.00204	CcSEcCtD
Chlorthalidone—Asthenia—Epirubicin—thyroid cancer	0.0016	0.002	CcSEcCtD
Chlorthalidone—Diarrhoea—Epirubicin—thyroid cancer	0.00152	0.00191	CcSEcCtD
Chlorthalidone—Hypersensitivity—Doxorubicin—thyroid cancer	0.00152	0.0019	CcSEcCtD
Chlorthalidone—Asthenia—Doxorubicin—thyroid cancer	0.00148	0.00185	CcSEcCtD
Chlorthalidone—Dizziness—Epirubicin—thyroid cancer	0.00147	0.00184	CcSEcCtD
Chlorthalidone—SLC12A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00142	0.0164	CbGpPWpGaD
Chlorthalidone—SLC12A1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00142	0.0164	CbGpPWpGaD
Chlorthalidone—Vomiting—Epirubicin—thyroid cancer	0.00141	0.00177	CcSEcCtD
Chlorthalidone—Diarrhoea—Doxorubicin—thyroid cancer	0.00141	0.00176	CcSEcCtD
Chlorthalidone—Rash—Epirubicin—thyroid cancer	0.0014	0.00176	CcSEcCtD
Chlorthalidone—Dermatitis—Epirubicin—thyroid cancer	0.0014	0.00176	CcSEcCtD
Chlorthalidone—Headache—Epirubicin—thyroid cancer	0.00139	0.00175	CcSEcCtD
Chlorthalidone—Dizziness—Doxorubicin—thyroid cancer	0.00136	0.00171	CcSEcCtD
Chlorthalidone—Nausea—Epirubicin—thyroid cancer	0.00132	0.00166	CcSEcCtD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.00132	0.0152	CbGpPWpGaD
Chlorthalidone—Vomiting—Doxorubicin—thyroid cancer	0.00131	0.00164	CcSEcCtD
Chlorthalidone—Rash—Doxorubicin—thyroid cancer	0.0013	0.00163	CcSEcCtD
Chlorthalidone—Dermatitis—Doxorubicin—thyroid cancer	0.0013	0.00162	CcSEcCtD
Chlorthalidone—SLC12A3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00129	0.0149	CbGpPWpGaD
Chlorthalidone—SLC12A3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00129	0.0149	CbGpPWpGaD
Chlorthalidone—Headache—Doxorubicin—thyroid cancer	0.00129	0.00162	CcSEcCtD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.00126	0.0146	CbGpPWpGaD
Chlorthalidone—Nausea—Doxorubicin—thyroid cancer	0.00122	0.00153	CcSEcCtD
Chlorthalidone—SLC12A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00107	0.0123	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—MINPP1—thyroid cancer	0.00104	0.012	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—MINPP1—thyroid cancer	0.000971	0.0112	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—MINPP1—thyroid cancer	0.000971	0.0112	CbGpPWpGaD
Chlorthalidone—SLC12A3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000968	0.0112	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—MINPP1—thyroid cancer	0.000899	0.0104	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—NDUFA13—thyroid cancer	0.000884	0.0102	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—CHST14—thyroid cancer	0.000831	0.0096	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—NDUFA13—thyroid cancer	0.000825	0.00953	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—NDUFA13—thyroid cancer	0.000825	0.00953	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—PTGS2—thyroid cancer	0.000791	0.00913	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—CHST14—thyroid cancer	0.000776	0.00896	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—CHST14—thyroid cancer	0.000776	0.00896	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—NDUFA13—thyroid cancer	0.000765	0.00883	CbGpPWpGaD
Chlorthalidone—SLC12A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000723	0.00836	CbGpPWpGaD
Chlorthalidone—SLC12A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000723	0.00836	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—CHST14—thyroid cancer	0.000719	0.0083	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—MINPP1—thyroid cancer	0.000717	0.00828	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—CCND1—thyroid cancer	0.000714	0.00825	CbGpPWpGaD
Chlorthalidone—SLC12A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000712	0.00822	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—EPO—thyroid cancer	0.000699	0.00807	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—MINPP1—thyroid cancer	0.000688	0.00794	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—HPGD—thyroid cancer	0.00067	0.00774	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—MINPP1—thyroid cancer	0.000659	0.00761	CbGpPWpGaD
Chlorthalidone—SLC12A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000657	0.00759	CbGpPWpGaD
Chlorthalidone—SLC12A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000657	0.00759	CbGpPWpGaD
Chlorthalidone—SLC12A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000646	0.00746	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—HPGD—thyroid cancer	0.000626	0.00723	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—HPGD—thyroid cancer	0.000626	0.00723	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—NRAS—thyroid cancer	0.000615	0.00711	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—NDUFA13—thyroid cancer	0.00061	0.00704	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—NDUFA13—thyroid cancer	0.000585	0.00675	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—HPGD—thyroid cancer	0.00058	0.00669	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—MINPP1—thyroid cancer	0.00058	0.00669	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—CHST14—thyroid cancer	0.000573	0.00662	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—NDUFA13—thyroid cancer	0.000561	0.00647	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—CHST14—thyroid cancer	0.00055	0.00635	CbGpPWpGaD
Chlorthalidone—SLC12A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000542	0.00625	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—KRAS—thyroid cancer	0.00053	0.00612	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—CHST14—thyroid cancer	0.000527	0.00609	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—NDUFA13—thyroid cancer	0.000493	0.00569	CbGpPWpGaD
Chlorthalidone—SLC12A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000492	0.00568	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—CHST14—thyroid cancer	0.000463	0.00535	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—HPGD—thyroid cancer	0.000462	0.00534	CbGpPWpGaD
Chlorthalidone—SLC12A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000455	0.00526	CbGpPWpGaD
Chlorthalidone—CA1—C-MYB transcription factor network—HRAS—thyroid cancer	0.00045	0.0052	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—HPGD—thyroid cancer	0.000443	0.00512	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—HPGD—thyroid cancer	0.000425	0.00491	CbGpPWpGaD
Chlorthalidone—CA9—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000424	0.00489	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—HIF1A—thyroid cancer	0.000416	0.0048	CbGpPWpGaD
Chlorthalidone—SLC12A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000413	0.00477	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—TPR—thyroid cancer	0.000385	0.00445	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—PRKAR1A—thyroid cancer	0.000379	0.00437	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—HPGD—thyroid cancer	0.000373	0.00431	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—TPR—thyroid cancer	0.000359	0.00415	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—TPR—thyroid cancer	0.000359	0.00415	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—PRKAR1A—thyroid cancer	0.000353	0.00408	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—PRKAR1A—thyroid cancer	0.000353	0.00408	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—TPR—thyroid cancer	0.000333	0.00384	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—PRKAR1A—thyroid cancer	0.000327	0.00378	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—SLC5A5—thyroid cancer	0.000288	0.00333	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—SLC5A5—thyroid cancer	0.000269	0.00311	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—SLC5A5—thyroid cancer	0.000269	0.00311	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—TPR—thyroid cancer	0.000265	0.00307	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—PRKAR1A—thyroid cancer	0.000261	0.00302	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—TPR—thyroid cancer	0.000254	0.00294	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—PRKAR1A—thyroid cancer	0.00025	0.00289	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—SLC5A5—thyroid cancer	0.000249	0.00288	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—TPR—thyroid cancer	0.000244	0.00282	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—RXRA—thyroid cancer	0.000242	0.0028	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—PRKAR1A—thyroid cancer	0.00024	0.00277	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—RXRA—thyroid cancer	0.000226	0.00261	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—RXRA—thyroid cancer	0.000226	0.00261	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—TPR—thyroid cancer	0.000214	0.00248	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—PRKAR1A—thyroid cancer	0.000211	0.00244	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—RXRA—thyroid cancer	0.000209	0.00242	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—SLC5A5—thyroid cancer	0.000199	0.0023	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—SLC5A5—thyroid cancer	0.00019	0.0022	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—SLC5A5—thyroid cancer	0.000183	0.00211	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—RXRA—thyroid cancer	0.000167	0.00193	CbGpPWpGaD
Chlorthalidone—CA9—Cellular responses to stress—TP53—thyroid cancer	0.000166	0.00191	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—SLC5A5—thyroid cancer	0.000161	0.00185	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—RXRA—thyroid cancer	0.00016	0.00185	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—RXRA—thyroid cancer	0.000153	0.00177	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—PPARG—thyroid cancer	0.000153	0.00177	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—PPARG—thyroid cancer	0.000143	0.00165	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—PPARG—thyroid cancer	0.000143	0.00165	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—RXRA—thyroid cancer	0.000135	0.00156	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—PPARG—thyroid cancer	0.000132	0.00153	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—PTGS2—thyroid cancer	0.00012	0.00139	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—PTGS2—thyroid cancer	0.000112	0.0013	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—PTGS2—thyroid cancer	0.000112	0.0013	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—PPARG—thyroid cancer	0.000105	0.00122	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—PTEN—thyroid cancer	0.000105	0.00121	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—PTGS2—thyroid cancer	0.000104	0.0012	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—PPARG—thyroid cancer	0.000101	0.00117	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—PTEN—thyroid cancer	9.79e-05	0.00113	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—PTEN—thyroid cancer	9.79e-05	0.00113	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—PPARG—thyroid cancer	9.69e-05	0.00112	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—PTEN—thyroid cancer	9.07e-05	0.00105	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—PPARG—thyroid cancer	8.52e-05	0.000984	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—PTGS2—thyroid cancer	8.29e-05	0.000958	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—PTGS2—thyroid cancer	7.95e-05	0.000918	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—PTGS2—thyroid cancer	7.62e-05	0.00088	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—PTEN—thyroid cancer	7.23e-05	0.000835	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—PTEN—thyroid cancer	6.93e-05	0.000801	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—PTGS2—thyroid cancer	6.7e-05	0.000774	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—PTEN—thyroid cancer	6.65e-05	0.000768	CbGpPWpGaD
Chlorthalidone—CA5A—Metabolism—AKT1—thyroid cancer	6.04e-05	0.000698	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—PTEN—thyroid cancer	5.84e-05	0.000675	CbGpPWpGaD
Chlorthalidone—CA5B—Metabolism—AKT1—thyroid cancer	5.64e-05	0.000652	CbGpPWpGaD
Chlorthalidone—CA7—Metabolism—AKT1—thyroid cancer	5.64e-05	0.000652	CbGpPWpGaD
Chlorthalidone—CA12—Metabolism—AKT1—thyroid cancer	5.23e-05	0.000604	CbGpPWpGaD
Chlorthalidone—CA4—Metabolism—AKT1—thyroid cancer	4.17e-05	0.000481	CbGpPWpGaD
Chlorthalidone—CA2—Metabolism—AKT1—thyroid cancer	4e-05	0.000461	CbGpPWpGaD
Chlorthalidone—CA1—Metabolism—AKT1—thyroid cancer	3.83e-05	0.000442	CbGpPWpGaD
Chlorthalidone—CA9—Metabolism—AKT1—thyroid cancer	3.37e-05	0.000389	CbGpPWpGaD
